Back to Search Start Over

The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells.

Authors :
Scotlandi, Katia
Manara, Maria Cristina
Serra, Massimo
Benini, Stefania
Maurici, Daniela
Caputo, Antonella
De Giovanni, Carla
Lollini, Pier-Luigi
Nanni, Patrizia
Picci, Piero
Campanacci, Mario
Baldini, Nicola
Source :
Oncogene. 1/21/99, Vol. 18 Issue 3, p739-746. 8p.
Publication Year :
1999

Abstract

The relationship between P-glycoprotein expression and malignancy is controversial. We have recently found that, in osteosarcoma, multidrug resistance (MDR) is associated with a less aggressive behavior, both in vitro and in clinical settings. In this study, we evaluated whether P-glycoprotein overexpression has a cause-effect relationship with the reduced metastatic potential of MDR cells, or rather reflects a more complex phenotype. MDR1 gene-transfected osteosarcoma cell clones, showing different levels of P-glycoprotein expression, were analysed for their in vitro characteristics and their tumorigenic and metastatic ability in athymic mice. Apart from the different levels of P-glycoprotein, no significant change in the expression of surface antigens or in the differentiative features were observed in the MDR1 gene transfectants compared to the parental cell lines or control clones, obtained by transfection with neo gene alone. In contrast to controls, however, MDR1 transfectants showed a significantly lower ability to grow in semi-solid medium and were completely unable to grow and give lung metastases in athymic mice. These findings indicate that P-glycoprotein overexpression is causally associated with a low malignant potential of osteosarcoma cells, and open new insights on the role and functions of P-glycoprotein activity. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09509232
Volume :
18
Issue :
3
Database :
Academic Search Index
Journal :
Oncogene
Publication Type :
Academic Journal
Accession number :
11352179
Full Text :
https://doi.org/10.1038/sj.onc.1202330